In Vitro models of inhalation toxicity and disease: The report of a FRAME workshop

ATLA Alternatives to Laboratory Animals

Volumn 37, Issue 1, 2009, Pages 89-141

  Bérubé, Kelly ^a   Aufderheide, Michaela ^b   Breheny, Damien ^c   Clothier, Richard ^d   Combes, Robert ^d   Duffin, Rodger ^e   Forbes, Ben ^f   Gaça, Marianna ^c   Gray, Alison ^g,r   Hall, Ian ^h   Kelly, Michael ⁱ   Lethem, Michael ^j   Liebsch, Manfred ^k   Merolla, Leona ^l   Morin, Jean Paul ^m   Seagrave, Jeanclare ⁿ   Swartz, Melody A ^o   Tetley, Teresa D ^p   Umachandran, Meera ^q,s  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Cultex Laboratories GmbH   (Germany)

^c BRITISH AMERICAN TOBACCO   (United Kingdom)

^d RUSSELL AND BURCH HOUSE   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g Covalab SARL ^*  (France)

^h QUEEN S MEDICAL CENTRE   (United Kingdom)

ⁱ Harlow Laboratories   (United Kingdom)

^j UNIVERSITY OF BRIGHTON   (United Kingdom)

^k FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^l UNILEVER RESEARCH   (United Kingdom)

^m UNIVERSITÉ DE ROUEN   (France)

ⁿ LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^o EPFL   (Switzerland)

^p NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^q RENEURON LTD   (United Kingdom)

^r La Croix Saint Ouen   (France)

^s PUBLIC HEALTH ENGLAND   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CIGARETTE SMOKE; NANOPARTICLE; TOXIC SUBSTANCE;

ADULT RESPIRATORY DISTRESS SYNDROME; AEROSOL; ASTHMA; BLOOD BRAIN BARRIER; BRONCHUS MUCOSA; CELL CULTURE; CELL LINE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONFERENCE PAPER; CYTOTOXICITY; DOSIMETRY; EMPHYSEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; EXHAUST GAS; EXPERIMENTAL MODEL; FLUORESCENCE MICROSCOPY; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INHALATION; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG DISEASE; LUNG FIBROSIS; LUNG PARENCHYMA; LUNG TOXICITY; MUCOCILIARY CLEARANCE; NONHUMAN; PARTICULATE MATTER; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAMAN SPECTROMETRY; RESPIRATORY SYSTEM; RESPIRATORY TRACT MUCOSA; RISK ASSESSMENT; SMALL AIRWAY DISEASE; SQUAMOUS CELL METAPLASIA; TOXICITY TESTING; TRACHEA;

AIR POLLUTANTS; ANIMAL TESTING ALTERNATIVES; ANIMALS; DISEASE MODELS, ANIMAL; EDUCATION; EUROPEAN UNION; HUMANS; INHALATION EXPOSURE; LUNG DISEASES; PARTICULATE MATTER; RESPIRATORY MUCOSA; RISK ASSESSMENT;

EID: 64849086385     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (247)

1. Mossman, B.T., Borm, P.J., Castranova, V., Costa, D.L., Donaldson, K. & Kleeberger, S.R. (2007).
2. Mechanisms of action of inhaled fibers, particles and nanoparticles in lung and cardiovascular diseases. Particle & Fibre Toxicology 4: 4. doi:10.1186/1743-8977-4-4. Available at: http://www. particleandfibretoxicology.com/content/4/1/4 (Accessed 08.01.09).
3. Stone, V. (2000). Environmental air pollution. American Journal of Respiratory & Critical Care Medicine 162, S44-S47.
4. BéruBé, K.A., Jones, C. & Jones, T.P. (2008). High resolution electron microscopy of environmental nanoparticles: factors for respiratory toxicologists. Proceedings of the Royal Microscopy Society 9, 2-14.
5. European Commission (2001). White Paper - Strategy for a Future Chemicals Policy. COM (20010) 88 Final, 321pp. Brussels, Belgium: Commission of the European Communities.
6. European Commission (2006). Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/ EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Official Journal of the European Union L396/1, 1-849.
7. Grindon, C. (2007). The new EU REACH Regulation has finally been adopted: Is this the end of the campaign trail. or just the beginning? ATLA 35, 239-242.
8. EEC (1976). Council Directive 76/768/EEC of 27 July 1976 on the approximation of the Laws of the Member States relating to cosmetic products. Official Journal of the European Communities L262, 169-200.
9. EU (2003). Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products. Official Journal of the European Union L66, 26-35.
10. Eskes, C. & Zuang, V. (eds) (2005). Alternative (non-animal) methods for cosmetics testing: current status and future prospects. ATLA 33, Suppl. 1, 1-228.
11. Hartings, J.M. & Roy, C.J. (2004). The automated bioaerosol exposure system: Preclinical platform development and a respiratory dosimetry application with nonhuman primates. Journal of Pharmacological & Toxicological Methods 49, 39-55.
12. Coffman, R.L. & Hessel, E.M. (2005). Non-human primate models of asthma. Journal of Experimental Medicine 201, 1875-1879.
13. Kimber, I., Agius, R., Basketter, D.A., Corsini, E., Cullinan, P., Dearman, R.J., Gimenez-Arnau, E., Greenwell, L., Hartung, T., Kuper, F., Maestrelli, P., Roggen, E. & Rovida, C. (2007). Chemical respiratory allergy: opportunities for hazard identification and characterisation. The report and recommendations of ECVAM Workshop 60. ATLA 35, 243-265.
14. Ling, G., Gu, J., Genter, M.B., Zhuo, X. & Ding, X. (2004). Regulation of cytochrome P450 gene expression in the olfactory mucosa. Chemico- biological Interactions 147, 247-258.
15. Coecke, S., Ahr, H., Blaauboer, B.J., Bremer, S., Casati, S., Castell, J., Combes, R., Corvi, R., Crespi, C.L., Cunningham, M.L., Elaut, G., Eletti, B., Freidig, A., Gennari, A., Ghersi-Egea, J-F., Guill- ouzo, A., Hartung, T., Hoet, P., Ingelman-Sundberg, M., Munn, S., Jassens, W., Ladstetter, B., Leahy, D., Long, A., Meneguz, A., Monshouwer, M., Morath, S., Nagelkerke, F., Pelkonen, O., Ponti, J., Prieto, P., Richert, L., Sabbioni, E., Schaack, B., Steiling, W., Testai, E., Vericat, J-A. & Worth, A. (2006). Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM Workshop 54. ATLA 34, 49-84.
16. Fisher, A.B. & Chander, A. (1985). Intracellular processing of surfactant lipids in the lung. Annual Review of Physiology 47, 789-802.
17. Müller, B., Seifart, K. & Barth, F. (1998). Effect of air pollutants on the pulmonary surfactant system. European Journal of Clinical Investigation 28, 762-777.
18. Agius, R. (2007). Occupational & Environmental Lung Disease. Health, Environment and Work website. Available at: http://www.agius.com/hew/ resource/lung.htm (Accessed 08.12.09).
19. Wyman, T.H., Bjornsen, A.J., Elzi, D.J., Smith, C.W., England, KM., Kelher, M. & Silliman, C.C. (2002). A two-insult in vitro model of PMN-medi- ated pulmonary endothelial damage: requirements for adherence and chemokine release. American Journal of Physiology: Cell Physiology 283, C1592-C1603.
20. King, T.E. (2005). Clinical advances in the diagnosis and therapy of the interstitial lung diseases. American Journal of Respiratory & Critical Care Medicine 172, 268-279.
21. Fox, J.C. & Fitzgerald, M.F. (2004). Models of chronic obstructive ulmonary disease: a review of current status. Drug Discovery Today: Disease Models 1, 319-328.
22. Puljic, R. & Pahl, A. (2004). Smoke induced changes in epithelial cell gene expression: development of an in vitro model for COPD. ALTEX 21, 3-7.
23. Nemery, B., Bast, A., Behr, J., Borm, P.J.A., Bourke, S.J., Camus, P., De Vuyst, P., Jansen, H.M., Kinnula, V.L., Lison, D., Pelkonen, O. & Saltini, C. (2001). Interstitial lung disease induced by exogenous agents: factors governing susceptibility. European Respiratory Journal 18, 30S-42S.
24. Mossman, B.T. (1990). In vitro studies on the biologic effects of fibers: correlation with in vivo bioas- says. Environmental Health Perspectives 88, 319-322.
25. Zhang, H.Y., Gharaee-Kermani, M., Zhang, K., Karmiol, S. & Phan, S.H. (1996). Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. American Journal of Pathology 148, 527- 537.
26. Miller, B.E. & Hook, G.E.R. (1990). Hypertrophy and hyperplasia of alveolar type 11 cells in response to silica and other pulmonary toxicants. Environmental Health Perspectives 85, 15-23.
27. Moeller, A., Rodriguez-Lecompte, J.C, Wang, L., Gauldie, J. & Kolb, M. (2006). Models of pulmonary fibrosis. Drug Discovery Today: Disease Models 3, 243-249.
28. Zosky, G.R. & Sly, P.D. (2007). Animal models of asthma. Clinical & Experimental Allergy 37, 973- 988.
29. Boyce, J.A. & Austen, K.F. (2005). No audible wheezing: nuggets and conundrums from mouse asthma models. Journal of Experimental Medicine 201, 1869-1873.
30. Shapiro, S.D. (2006). Pro/Con Editorial. Animal models of asthma. Pro: Allergic avoidance of animal (model[s]) is not an option. American Journal of Respiratory & Critical Care Medicine 174, 1171-1173.
31. Vanoirbeek, J.A.J., Toussaint, G., Nemery, B. & Hoet, P.M.H. (2006). Reduced exercise capacity in a mouse model of asthma. Thorax 61, 736-737.
32. Bartlett, N.W., Walton, R.P., Edwards, M.R., Aniscenko, J., Caramori, G., Zhu, J., Glanville, N., Choy, K.J., Jourdan, P., Burnet, J., Tuthill, T.J., Pedrick, M.S., Hurle, M.J., Plumpton, C., Sharp, N.A., Bussell, J.N., Swallow, D.M., Schwarze, J., Guy, B., Walmond, J., Jeffery, P.K., Lloyd, C.M., Papi, A., Killington, R.A., Rowlands, D.J., Blair, E.D., Clarke, N.J. & Johnston, S.L. (2008). Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nature Medicine 14, 199-204.
33. Kips, J.C, Tournoy, K.G. & Pauwels, R.A. (2000). Gene knockout models of asthma. American Journal of Respiratory & Critical Care Medicine 162, S66-S70.
34. Choe, M.M., Sporn, P.H.S. & Swartz, M.A. (2003). An in vitro airway wall model of remodelling. American Journal of Physiology: Lung Cellular & Molecular Physiology 285, L427-L433.
35. Choe, M.M., Tomei, A.A. & Swartz, M.A. (2006). 3D tissue model of the airway wall and mucosa. Nature Protocols 1, 357-362.
36. Choe, M.M., Sporn, P.H.S. &. Swartz, M.A. (2006). Extracellular matrix remodeling by dynamic strain in a three-dimensional tissue-engineered human airway wall model. American Journal of Respiratory Cellular & Molecular Biology 35, 306-313.
37. Dorger, M., Allmeling, A-M., Neuber, A., Behr, J., Rambeck, W. & Krombach, F. (1997). Interspecies comparison of rat and hamster alveolar macrophage antioxidative and oxidative capacity. Environmental Health Perspectives 105, Suppl. 5: Particle Toxicity, 1309-1312.
38. Kikkawa, Y. & Spitzer, R. (2005). Inclusion bodies of type II alveolar cells: Species differences and morphogenesis. Anatomical Record 163, 525-541.
39. Corcoran, B.M., Dukes-McEwan, J., French, A., Fuentes, V.L., Rhind, S., Cobb, M., Boswood, A. &. Martin, M.W.S. (1999). Chronic pulmonary disease in West Highland White Terriers. Veterinary Record 144, 611-616.
40. Corcoran, B.M. (2004). Idiopathic pulmonary fibrosis of the West Highland White Terrier. Proceedings of the 29th World Congress of the Small Animal Veterinary Association, 6-9 October 2004, Rhodes, Greece. Available at: http://www.vin.com/ proceedings/Proceedings.plx?CID=WSAVA2004& PID=8754&0=Generic (Accessed 08.01.09).
41. Norris, A.J., Naydan, D.K. & Wilson, D.W. (2005). Interstitial lung disease in West Highland White Terriers. Veterinary Patholology 42, 35-41.
42. Norris, C.R., Griffey, S.M. & Walsh, P. (2002). Use of keyhole lung biopsy for diagnosis of interstitial lung diseases in dogs and cats: 13 cases (1998- 2001). Journal of the American Veterinary Medical Association 221, 1453-1459.
43. Baran, CP., Opalek, J.M., McMaken, S., Newland, C.A., O'Brien Jr, J.M., Hunter, M.G., Bringardner, B.D., Monick, M.M., Brigstock, D.R., Stromberg, P.C., Hunninghake, G.W. & Marsh, C.B. (2007). Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis. American Journal of Respiratory & Critical Care Medicine 176, 78-89.
44. Coraux, C, Hajj, R., Lesimple, P. & Puchelle, E. (2005). In vivo models of human airway epithelium repair and regeneration. European Respiratory Review 14, 131-136.
45. Ware, L.B. (2007). Modelling human lung disease in animals. American Journal of Physiology: Lung Cellular & Molecular Physiology 294, L149-L150.
46. Moore, B.B. & Hogaboam, CM. (2008). Murine models of pulmonary fibrosis. American Journal of Physiology: Lung Cellular & Molecular Physiology 294, L152-L160.
47. Beckmann, N., Zurbruegg, S. & Ble, F-X. (2007). Non-invasive methods: Investigation of airways diseases by MRI in rats. ALTEX 24, Special Issue, 12-15.
48. Lutter, R. & Spiteri, M. (2005). Current perspectives in epithelial cell injury and repair: consequences for epithelial functions. European Respiratory Review 14, 126-130.
49. Catallo, W.J., Kennedy, C.H., Henk, W., Barker, S.A., Grace, S.C & Penn, A. (2001). Combustion products of 1,3-butadiene are cytotoxic and geno- toxic to human bronchial epithelial cells. Environmental Health Perspectives 109, 965-971.
50. Pauluhn, J. & Mohr, U. (2000). Inhalation studies in laboratory animals : Current concepts and alternatives. Toxicologic Pathology 28, 734-753.
51. Sakagami, M. (2006). In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Advanced Drug Delivery Reviews 58, 1030-1060.
52. Anon. (2007). Globally Harmonized System of Classification & Labelling of Chemicals. Second Revision. Available at: http://www.unece.org/ trans/danger/publi/ghs/ghs-rev02/02files-e.html (Accessed 08.01.09).
53. OECD (2004). Draft Proposal for a New Guideline: 433 Acute Inhalation Toxicity -Fixed Concentration Procedure, 2nd version, 24pp. Paris, France: Environment Directorate, Organisation for Economic Co-operation and Development. Available at: http://www.oecd.Org/dataoecd/63/7/32035886.pdf (Accessed 08.01.09).
54. OECD (2008). Draft Proposal for a New Guideline: 436. Acute Inhalation Toxicity - Acute Toxic Class (ATC) Method, 29pp. Paris, France: Environment Directorate, Organisation for Economic Co-operation and Development. Available at: http://www.oecd.org/dataoecd/54/ll/41761436.pdf (Accessed 13.02.09).
55. OECD (2008). Draft Proposal for a Revised Guideline 412 Subacute Inhalation Toxicity: 28- day Study (Version 4), 15pp. Paris, France: Environment Directorate, Organisation for Economic Co-operation and Development. Available at: http://www.oecd.org/dataoecd/62/29/41460817.pdf (Accessed 13.02.09).
56. OECD (2004). Draft Guidance Document on Acute Inhalation Toxicity Testing, Series on Testing and
57. Assessment No. 39B, 23pp. Paris, France: Environment Directorate, Organisation for Economic Co-operation and Development. Available at: http://www.oecd.org/LongAbstract/0,3425,en-2649-201185-34029469-l-l-l-l,00.html (Accessed 08.01.09).
58. Dorato, M.A. (1990). Overview of inhalation toxicology. Environmental Health Perspectives 85, 163-170.
59. McMahon, T.A., Brain, J.D. & Lemott, S. (1977). Species differences in aerosol deposition. In Inhaled particles TV: Proceedings of an International Symposium (ed. W.H. Walton & B. McGovern), Part 1, September 1975, Edinburgh, United Kingdom, pp. 23-33. Oxford, UK: Perg- amon Press.
60. Pauluhn, J., Bury, D., Föst, U., Gamer, A., Hoer- nicke, E., Hofmann, T., Kunde, M., Neustadt, T., Schlede, E., Schnierle, H., Wettig, K. & Westphal, D. (1996). Acute inhalation toxicity testing: considerations of technical and regulatory aspects. Archives of Toxicology 71, 1-10.
61. Pauluhn, J. (2003). Overview of testing methods used in inhalation toxicity: from facts to artefacts. Toxicology Letters 140-141, 183-193.
62. Alarie, Y. (2004). Lecture Notes. Inhalation Toxicology & Toxic Responses of the Lung. Pittsburgh, PA, USA: University of Pittsburgh, Graduate School of Public Health.
63. Zwart, A., Arts, J.H., ten Berge, W.F. & Appelman, L.M. (1992). Alternative acute inhalation toxicity testing by determination of the concentration- time-mortality relationship: experimental comparison with standard LC50 testing. Regulatory Toxicology & Pharmacology 15, 278-290.
64. Combes, R.D., Gaunt, I. & Balls, M. (2004). A scientific and animal welfare assessment of the OECD Health Effects Test Guidelines for the safety testing of chemicals under the European Union REACH system. ATLA 32, 163-208.
65. Chivers, S. (2007). Approaches to minimise animal use in inhalation toxicity studies. Toxicology 231, 96-97.
66. Stallard, N., Whitehead, A. & Indans, I. (2003). Statistical evaluation of the Fixed Concentration Procedure for acute inhalation toxicity assessment. Human & Experimental Toxicology 22, 575-585.
67. Grainger, C, Greenwell, L.L., Lockley, D.J., Martin, G.P. & Forbes, B. (2006). Culture of Calu- 3 cells at the air-liquid interface provides a representative model of the airway epithelial barrier. Pharmaceutical Research 23, 1482-1490.
68. Penn, A., Murphy, G., Barker, S., Henk, W. & Penn, L. (2005). Combustion-derived ultrafine particles transport organic toxicants to target respiratory cells. Environmental Health Perspectives 113, 956-963.
69. Forbes, B., Shah, A., Martin, G.P., Lansley, A.B. & Martin, G.P. (2003). The human bronchial epithelial cell line 16HBE14o- as a model system of the airways for studying drug transport. International Journal of Pharmaceutics 257, 161-167.
70. Gray, A.C., McLeod, J.D. & Clothier, R.H. (2007). A review of in vitro modelling approaches to the identification and modulation of squamous metaplasia in the human tracheobronchial epithelium. ATLA 35, 493-504.
71. BeruBe, K.A., Balharry, D., Jones, T.P., Moreno, T., Hayden, P., Sexton, K., Hicks, M., Merolla, L., Timblin, C, Shukla, A. & Mossman, B.T. (2006). Characterisation of airborne particulate matter and related mechanisms of toxicity: an experimental approach. In Air Pollution Reviews (ed. J. Ayres, R. Maynard & R. Richards), Volume 3, pp. 69-109. London, UK: Imperial College Press.
72. Forbes, B. & Ehrhardt, C. (2005). Human respiratory epithelial cell culture for drug delivery applications. European Journal of Pharmaceutics & Biopharmaceutics 60, 193-205.
73. Williams, M.C. (1984). Endocytosis in alveolar type II cells: effect of charge and size of tracers. Proceedings of the National Academy of Sciences of the USA 81, 6054-6058.
74. Witherden, I.R., Vanden Bon, E.J., Goldstraw, P., Ratcliffe, C, Pastorino, U. & Tetley, T.D. (2004). Primary human alveolar type II epithelial cell chemokine release - effects of cigarette smoke and neutrophil elastase. American Journal of Respiratory Cellular & Molecular Biology 30, 500-509.
75. Fang, X., Song, Y., Hirsch, J., Galietta, L.J.V., Pedemonte, N., Zemans, R.L., Dolganov, G., Verkman, A.S., & Matthay, M.A. (2006). Contribution of CFTR to apical- basolateral fluid transport in cultured human alveolar epithelial type II cells. American Journal of Physiology: Lung Cellular & Molecular Physiology 290, 242-249.
76. BeruBe, K, Balharry, D., Sexton, K., Koshy, L. & Jones, T. (2007). Combustion-derived nanoparticles: mechanisms of pulmonary toxicity. Clinical & Experimental Pharmacology & Physiology 34, 1044-1050.
77. Hermanns, M.I., Unger, R.E., Kehe, K., Peters, K. & Kirkpatrick, C.J. (2004). Lung epithelial cell lines in coculture with human pulmonary microvascular endothelial cells: development of an alveolo-capillary barrier in vitro. Laboratory Investigation 84, 736-752.
78. Forbes, B. (2000). Human airway epithelial cell lines for in vitro drug transport and metabolism studies. Pharmaceutical Science & Technology Today 3, 18-27.
79. Kaartinen, L., Nettesheim, P., Adler, K.B. & Randell, S.H. (1993). Rat tracheal epithelial cell differentiation in vitro. In Vitro Cellular & Developmental Biology: Animal 29A, 481-492.
80. Ehrhardt, C, Kneuer, C, Fiegel, J., Hanes, J., Schaefer, U., Kim, K-J. & Lehr, C-M. (2004). Influence of apical fluid volume on the development of functional intercellular junctions in the human epithelial cell line 16HBE14o-: implications for the use of this cell line as an in vitro model for bronchial drug absorption studies. Cell & Tissue Research 308, 391-400.
81. Florea, B.I., van der Sandt, I.C.J., Schrier, S.M., Kooiman, K., Deryckere, K., de Boer, A.G., Jung- inger, H.E. & Borchard, G. (2001). Evidence of P- glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3). British Journal of Pharmacology 134, 1555-1563.
82. Pearson, R.G., Bhandari, R., Quirk, R.A. & Shakesheff, K.M. (2002). Recent advances in tissue engineering: An invited Review. Journal of Long- term Effects of Medical Implants 12, 1-33.
83. Sexton, K., Balharry, D. & BeruBe, K.A. (2008).
84. Genomic biomarkers of pulmonary exposure to tobacco smoke components. Pharmacogenetics & Genomics 18, 853-860.
85. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65, 207-212.
86. Crouch, S.P.M., Kozlowski, R., Slater, K.J. & Fletcher, J. (1993). The use of ATP biolumines- cence as a measure of cell proliferation and cytotoxicity. Journal of Immunological Methods 160, 81-88.
87. Balharry, D., Sexton, K. & BeruBe, K.A. (2008). An in vitro approach to assess the toxicity of inhaled tobacco smoke components: Nicotine, cadmium, formaldehyde and urethane. Toxicology 244, 66-76.
88. Blank, F., Rothen-Rutishauser, B.M., Schurch, S. & Gehr, P. (2006). An optimized in vitro model of the respiratory tract wall to study particle cell interactions. Journal of Aerosol Medicine 19, 392-405.
89. Zabner, J., Karp, P., Seiler, M., Phillips, S.L., Mitchell, C.J., Saavedra, M., Welsh, M. & Klingelhutz, A.J. (2003). Development of cystic fibrosis and noncystic fibrosis airway cell lines. American Journal of Physiology: Lung Cellular & Molecular Physiology 284, L844-L854.
90. Kim, D-D. (2007). In vitro cellular models for nasal drug absorption studies. In Drug Absorption Studies In Situ, In Vitro & In Silico Models (ed. C. Ehrhadt & K-J. Kim), pp. 216-234. New York, NY, USA: Springer.
91. Tetley, T. (2002). Macrophages and the pathogenesis of COPD. Chest 121, 156S-159S.
92. Tetley, T. (2005). Inflammatory cells and chronic obstructive pulmonary disease. Current Drug Targets - Inflammation & Allergy 4, 607-618.
93. Witherden, I.R. & Tetley, T.D. (2001). Isolation and culture of alveolar type II pneumocytes. Methods in Molecular Medicine 56, 137-146.
94. Riechelmann, H. (2004). Cellular and molecular mechanisms in environmental and occupational inhalation toxicology. GMS Current Topics in Otorhinolaryngology - Head & Neck Surgery 3: Doc02. Available at: http://www2.egms.de/en/jour- nals/cto/2004-3/cto000002.shtml (Accessed 08.01.09).
95. Lieber, M., Todaro, G., Smith, B., Szakal, A. & Nelson-Rees, W. (2006). A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. International Journal of Cancer 17, 62-70.
96. Fabbro, D., di Loreto, C, Stamerra, O., Beltrami, C.A., Lonigro, R. & Damante, G. (1996). TTF-1 gene expression in human lung tumors. European Journal of Cancer 32A, 512-517.
97. Fuchs, S., Hollins, A., Laue, M., Schaefer, U., Roemer, K., Gumbleton, M. & Lehr, C-M. (2003). Differentiation of human alveolar epithelial cells in primary culture: morphological characterization and synthesis of caveolin-1 and surfactant protein- C. Cell & Tissue Research 311, 31-45.
98. Kemp, S.J., Thorley, A.J., Gorelik, J., Seckl, M.J., O'Hare, M.J., Arcaro, A., Korchev, Y., Goldstraw, P. & Tetley, T.D. (2008). Immortalization of human alveolar epithelial cells to investigate nanoparticle uptake. American Journal of Respiratory Cell & Molecular Biology 39, 591-597.
99. Thorley, A.J., Ford, P.A., Giembycz, M.A., Goldstraw, P., Young, A. & Tetley, T.D. (2007). Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimu- lated primary human lung alveolar type II epithelial cells and macrophages. Journal of Immunology 178, 463-473.
100. Culpitt, S.V., Rogers, D.F., Shah, P., De Matos, C, Russell, R.E., Donnelly, L.E. & Barnes, P.J. (2003). Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. American Journal of Respiratory & Critical Care Medicine 167, 24-31.
101. Kendall, M., Tetley, T.D., Wigzell, E., Hutton, B., Nieuwenhuijsen, M. & Luckham, P. (2002). Lung lining liquid modifies PM2 5 in favour of particle aggregation: a protective mechanism. American Journal of Physiology: Lung Cellular & Molecular Physiology 282, L109-L114.
102. Ishii, H., Hayashi, S., Hogg, J.C., Fujii, T., Goto, Y., Sakamoto, N., Mukae, H., Vincent, R. & van Eeden, S.F. (2005). Alveolar macrophage-epithe- lial cell interaction following exposure to atmospheric particles induces the release of mediators involved in monocyte mobilization and recruitment. Respiratory Research 6, 87.
103. Barrett, E.G., Johnston, C., Oberdorster, G. & Finkelstein, J.N. (1998). Silica-induced chemokine expression in alveolar type II cells is mediated by TNF-a. American Journal of Physiology 275, L1110-L1119.
104. Tao, F. & Kobzik, L. (2002). Lung macrophage- epithelial cell interactions amplify particle- mediated cytokine release. American Journal of Respiratory Cellular & Molecular Biology 26, 499-505.
105. Rothen-Rutishauser, B.M., Kiama, S.G. & Gehr, P. (2005). A 3D cellular model of the human respiratory tract to study the interaction with particles. American Journal of Respiratory Cellular & Molecular Biology 32, 281-289.
106. Gehr, P., Blank, F. & Rothen-Rutishauser, B. (2006). Fate of inhaled particles after interaction with the lung surface. Paediatric Respiratory Reviews 7, S73-S75.
107. Bach, P.H., Vickers, A.E.M., Fisher, R., Baumann, A., Brittebo, E., Carlile, D.J., Koster, H.J., Lake, B.J., Salmon, F., Sawyer, T.W. & Skibinski, G. (1996). The use of tissue slices for pharmacotoxico- logical studies. The report and recommendations of ECVAM Workshop 20. ATLA 24, 893-923.
108. Thohan, S., Zurich, M., Chung, H, Weiner, M., Kane, A.S. & Rosen, M. (2001). Tissue slices revisited: evaluation and development of a short-term incubation for integrated drug metabolism. Drug Metabolism & Distribution 29, 1337-1342.
109. 2. Toxicology in Vitro 13, 467-473.
110. Umachandran, M., Howarth, J. & Ioannides, C. (2004). Metabolic and structural viability of precision-cut rat lung slices in culture. Xenobiotica 34, 771-780.
111. Smith, P.F., Gandolfi, A.J., Krumdieck, C.L., Put- man, C.W., Zukowski, C.F., Davis, W.M. & Brendel, K. (1985). Dynamic organ culture of precision liver slices for in vitro toxicology. Life Sciences 36, 1367- 1375.
112. Hashemi, E., Dobrota, M., Till, C. & Ioannides, C. (1999). Structural and functional integrity of precision-cut liver slices in xenobiotic metabolism: a comparison of the dynamic organ and multiwell plate culture procedures. Xenobiotica 29, 11-25.
113. Price, R.J., Renwick, A.B., Walters, D.G., Young, P.J. & Lake, B.G. (2004). Metabolism of nicotine and induction of CYP1A forms in precision-cut rat liver and lung slices. Toxicology in Vitro 18, 179-185.
114. 14C]- Ethoxycoumarin metabolism by precision-cut rat hepatic slices. Drug Metabolism & Disposition 24, 383-389.
115. de Graaf, I.A.M., Groothuis, G.M.M. & Olinga, P. (2007). Precision-cut tissue slices as a tool to predict metabolism of novel drugs. Expert Opinion on Drug Metabolism & Toxicology 3, 879-898.
116. 14C] agaritine by precision-cut rat, mouse and human liver and lung slices. Food & Chemical Toxicology 34, 603- 609.
117. Umachandran, M. & Ioannides, C. (2006). Stability of cytochromes P450 and phase II conjugation systems in precision-cut rat lung slices cultured up to 72 h. Toxicology 224, 14-21.
118. Pushparajah, D.S., Umachandran, M., Nazir, T., Plant, K.E., Plant, N., Lewis, D.F. & Ioannides, C. (2007). Up-regulation of CYP1A/B in rat lung and liver, and human liver precision-cut slices by a series of polycyclic aromatic hydrocarbons; association with the Ah locus and importance of molecular size. Toxicology in Vitro 22, 128-145.
119. Staal, Y.C.M., van Herwijnen, M.H.M., van Schooten, F.J. & van Delft, J.H.M. (2006). Modulation of gene expression and DNA adduct formation in HepG2 cells by polycyclic aromatic hydrocarbons with different carcinogenic potencies. Carcinogenesis 27, 646-655.
120. Coecke, S., Balls, M., Bowe, G., Davis, J., Gstraunthaler, G., Hartung, T., Hay, R., Merten, O- W., Price, A., Schechtman, L., Stacey, G. & Stokes, W. (2005). Guidance on Good Cell Culture Practice. A report of the Second ECVAM Task Force on Good Cell Culture Practice. ATLA 33, 261-287.
121. Takeyama, K., Fahy, J.V. & Nadel, J.A. (2001). Relationship of epidermal growth factor receptors to goblet cell production in human bronchi. American Journal of Respiratory & Critical Care Medicine 163, 511-516.
122. Rogers, D.F. (2003). The airway goblet cell. International Journal of Biochemistry & Cell Biology 35, 1-6.
123. Haswell, L., Thorne, D., Breheny, D. & Richter, A. (2007). An in vitro model for cigarette smoke induced goblet cell hyperplasia using flow cytometry. BfR congress on Alternative Test Methods in Inhalation Toxicology, 7-9 May 2007, Berlin, Germany. Available at: http://www.ctw-congress.de/atmit/atmit07programme-abstracts.pdf (Accessed 08.01.09).
124. Phillips, J., Kluss, B., Richter, A. & Massey, E.D. (2005). Exposure of bronchial epithelial cells to whole cigarette smoke: assessment of cellular responses. ATLA 33, 239-248.
125. Griffith, L.G. & Swartz, M.A. (2006). Capturing complex 3D tissue physiology in vitro. Nature Reviews: Molecular Cell Biology 7, 211-224.
126. Knight, D. (2001). Epithelium-fibroblast interactions in response to airway inflammation. Immunology & Cell Biology 79, 160-164.
127. Federov, I.A., Wilson, S.J., Davies, D.E. & Holgate, S.T. (2005). Epithelial stress and structural remodelling in childhood asthma. Thorax 60, 389-394.
128. Evans, M.J., Van Winkle, L.S., Fanucchi, M.V. & Plopper, C.G. (1999). The attenuated fibroblast sheath of the respiratory tract epithelial-mes- enchymal trophic unit. American Journal of Respiratory Cellular & Molecular Biology 21, 655-657.
129. Holgate, S.T. (2000). Epithelial damage and response. Clinical & Experimental Allergy 30, Suppl. 1, 37-41.
130. Holgate, S.T., Lackie, P.M., Howarth, P.H., Roche, W.R., Puddicombe, S.M., Richter, A., Wilson, S.J., Holloway, J.W. & Davies, D.E. (2001). Activation of the epithelial mesenchymal trophic unit in the pathogenesis of asthma. International Archives of Allergy & Immunology 124, 253-258.
131. Holgate, S.T. (2002). Asthma: more than an inflammatory disease. Mechanisms in allergy and adult asthma. Current Opinion in Allergy & Clinical Immunology 2, 27-29.
132. Knight, D.A., Lane, C.L. & Stick, S.M. (2004). Does aberrant activation of the epithelial- mesenchymal trophic unit play a key role in asthma or is it an unimportant sideshow? Current Opinion in Pharmacology 4, 251-256.
133. Zamora, P.O., Benson, J.M., Marshall, T.C., Mokler, B.V., Li, A.P., Dahl, A.R., Brooks, A.L. & McClellan, R.O. (1983). Cytotoxicity and mutagenicity of vapour-phase pollutants in rat lung epithelial cells and Chinese hamster ovary cells grown on collagen gels. Journal of Toxicology & Environmental Health 12, 27-38.
134. Chen, L.C., Fang, CP., Qu, Q.S., Fine, J.M. & Schlesinger, R.B. (1993). A novel system for the in vitro exposure of pulmonary cells to acid sulphate aerosols. Toxicological Science 20, 170-176.
135. Morin, J.P., Fouquet, F., Monteil, C, Le Prieur, E., Vaz, E. & Dionet, F. (1999). Development of a new system for continuous in vitro exposure of lung tissue to complex atmospheres: application to diesel exhaust toxicology. Cell Biology & Toxicology 15, 143-152.
136. Tippe, A., Heinzmann, U. & Roth, C. (2002). Deposition of fine and ultrafine aerosol particles during exposure at the air/cell interface. Journal of Aerosol Science 33, 207-218.
137. Cheng, M.D., Malone, B. & Storey, J.M.E. (2003). Monitoring cellular responses of engine emitted particles by using a direct air-cell interface deposition technique. Chemosphere 53, 237-243.
138. Cooney, D., Kazantseva, M. & Hickey, A.J. (2004). Development of a size-dependent aerosol deposition model utilising human airway epithelial cells for evaluating aerosol drug delivery. ATLA 32, 581-590.
139. Fiegel, J., Ehrhardt, C, Schaefer, U.F., Lehr, C-M. & Hanes, J. (2003). Large porous particle impingement on lung epithelial cell monolayers -toward improved particle characterization in the lung.
140. Pharmaceutical Research 20, 788-796.
141. Aufderheide, M. (2006). Experimental in vitro exposure methods for studying the effects of inhal- able compunds. In Cigarette Smoke & Oxidative Stress (ed. B.B. Halliwell & H.E. Poulsen), pp. 261-277. Berlin, Germany: Springer Verlag.
142. Aufderheide, M., Knebel, J.W. & Ritter, D. (2002). A method for the in vitro exposure of human cells to environmental and complex gaseous mixtures: application to various types of atmosphere. ATLA 30, 433-441.
143. Aufderheide, M. (2005). Direct exposure methods for testing native atmospheres. Experimental & Toxicologic Pathology 57, Suppl. 1, 213-226.
144. Knebel, D.W., Ritter, D. & Aufderheide, M. (2002). Exposure of human lung cells to native diesel motor exhaust - development of an optimized in vitro test strategy. Toxicology in Vitro 16, 185-192.
145. Pariselli, F., Sacco, M.G. & Rembges, D. (2006). Set-up of a dynamic in vitro exposure device for the study of indoor air pollutant effects on human derived cells. Environmental Toxicology 10, 231- 239.
146. Aufderheide, M. & Mohr, U. (2004). A modified CULTEX® system for the direct exposure of bacteria to inhalable substances. Experimental & Toxicologic Patholology 55, 451-454.
147. Aufderheide, M. & Gressmann, H. (2007). A modified Ames assay reveals the mutagenicity of native cigarette mainstream smoke and its gas vapour phase. Experimental & Toxicologic Pathology 58, 383-392.
148. Wolz, L., Krause, G., Scherer, G., Aufderheide, M. & Mohr, U. (2002). In vitro genotoxicity assay of sidestream smoke using a human bronchial epithelial cell line. Food & Chemical Toxicology 40, 845-850.
149. Kim, K.C., McCracken, K., Lee, B.C., Shin, C.Y., Jo, M.J., Lee, C.J.
150. Conway, J.D., Bartolotta, T., Abdullah, L.H. & Davis, C.W. (2003). Regulation of mucin secretion from human bronchial epithelial cells grown in murine hosted xenografts. American Journal of Physiology: Lung Cellular & Molecular Physiology 284, L945-L954.
151. Mio, T., Romberger, D.J., Thompson, A.B., Robbins, R.A., Heires, A. & Rennard, S.I. (1997). Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. American Journal of Respiratory & Critical Care Medicine 155, 1770-1776.
152. Richter, A., O'Donnell, R.A., Powell, R.M., Sanders, M.W., Holgate, S.T., Djukanovi, R. & Davies, D.E. (2002). Autocrine ligands for the epidermal growth factor receptor mediate interleukin-8 release from bronchial epithelial cells in response to cigarette smoke. American Journal of Respiratory Cellular & Molecular Biology 27, 85-90.
153. Rusznak, C, Mills, P.R., Devalia, J.L., Sapsford, R.J., Davies, R.J. & Lozewicz, S. (2000). Effect of cigarette smoke on the permeability and IL-ip and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers, and patients with chronic obstructive pulmonary disease. American Journal of Respiratory Cellular & Molecular Biology 23, 530-536.
154. Rusznak, C, Sapsford, R.J., Devalia, J.L., Shah, S.S., Hewitt, E.L., Lamont, A.G., Davies, R.J. & Lozewicz, S. (2001). Interaction of cigarette smoke and house dust mite allergens on inflammatory mediator release from primary cultures of human bronchial epithelial cells. Clinical & Experimental Allergy 31, 226-238.
155. Wagner, J.G., Van Dyken, S.J., Wierenga, J.R., Hotchkiss, J.A. & Harkema, J.R. (2003). Ozone exposure enhances endotoxin-induced mucous cell metaplasia in rat pulmonary airways. Toxic- ological Sciences 74, 437-446.
156. Wiethoff, A.J., Harkema, J.R., Koretsky, A.P. & Brown, W.E. (2001). Identification of mucosal injury in the murine nasal airways by magnetic resonance imaging: site-specific lesions induced by 3-methylindole. Toxicology & Applied Pharmacology 15, 68-75.
157. Wright, J.L. & Churg, A. (2002). Smoking cessation decreases the number of metaplastic secretory cells in the small airways of the guinea pig. Inhalation Toxicology 14, 1153-1159.
158. Habler, O., Kleen, M., Takenaka, S., Leiderer, R., Pusch, R., Welte, M., Zwissler, B. & Messmer, K. (1996). Eight hours' inhalation of prostacyclin (PGI2) in healthy lambs: effects on tracheal, bronchial and alveolar morphology. Intensive Care Medicine 22, 1232-1238.
159. Bonnet, P., Nunge, H., Gagnaire, F. & Zahm, J.M. (1994). Ex vivo technique for evaluating the effect of chemical vapour on mucociliary activity. Journal of Applied Toxicology 14, 369-374.
160. Durak, H., Ertay, T., Sayit, E., Aktogu, S., Kut, Ö., Güven, H. & G̈re, A. (1996). Lung clearance of aerosolized 99mTc erythromycin lactobionate in rabbits. Nuclear Medicine & Biology 23, 291-293.
161. Sabater, J.R., Mao, Y.M., Shaffer, C, James, M.K., O'Riordan, T.G. & Abraham, W.M. (1999). Aerosolisation of P2Y2-receptor agonists enhances mucociliary clearance in sheep. Journal of Applied Physiology 87, 2191-2196.
162. Rearick, J.L, Deas, M. & Jetten, A.M. (1987). Synthesis of mucous glycoproteins by rabbit tracheal cells in vitro. Modulation by substratum, retinoids and cyclic AMP. Biochemical Journal 242, 19-25.
163. Gray, T.E., Guzman, K., Davis, C.W., Abdullah, L.H. & Nettesheim, P. (1996). Mucociliary differentiation of serially passaged normal human tracheobronchial epithelial cells. American Journal of Respiratory Cellular & Molecular Biology 14, 104-112.
164. Kim, K.C. & Lee, B.C. (1991). P2 purinoreceptor regulation of mucin release by airway goblet cells in primary culture. British Journal of Pharmacology 103, 1053-1056.
165. Li, Y., Martin, L.D., Spizz, G. & Adler, KB. (2001). MARCKS protein is a key molecule regulating mucin secretion by human airway epithelial cells in vitro. Journal of Biological Chemistry 276, 40,982-40,990.
166. Laoukili, J., Perret, E., Willems, T., Minty, A., Parthoens, E., Houcine, O., Coste, A., Jorissen, M., Marano, M., Caput, D. & Tournier, F. (2001). IL-13 alters mucociliary differentiation and ciliary beating of human airway epithelial cells. Journal of Clinical Investigation 108, 1817-1824.
167. Atherton, H.C., Jones, G. & Danahay, H. (2003). IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3-kinase regulation. American Journal of Physiology: Lung Cellular & Molecular Physiology 285, L730-L739.
168. 2u purinoceptor regulation of mucin secretion in SP0C1 cells, a goblet cell line from the airways. Biochemical Journal 316, 943-951.
169. Morse, D.M., Smullen, J.L. & Davis, C.W. (2001). Differential effects of UTP, ATP and adenosine on ciliary activity of human nasal epithelial cells. American Journal of Physiology: Cell Physiology 280, C1485-C1497.
170. Peters, E.J., Morice, R., Benner, S.E., Lippman, S., Lukeman, J.L., Lee, J.S., Ro, J.Y. & Hong, W.K. (1993). Squamous metaplasia of the bronchial mucosa and its relationship to smoking. Chest 103, 1429-1432.
171. Araya, J., Cambier, S., Markovics, J.A., Wolters, P., Jablons, D., Hill, A., Finkbeiner, W., Jones, K., Broaddus, V.C., Sheppard, D., Barzcak, A., Xiao, Y., Erie, D.J. & Nishimura, S.L. (2007). Squamous metaplasia amplifies pathologic epithelial-mes- enchymal interactions in COPD patients. Journal of Clinical Investigation 117, 3551-3562.
172. Jetten, A.M. (1987). Multistep process of squamous differentiation of tracheobronchial epithelial cells: Role of retinoids. Dermatologica 175, Suppl. 1, 37-44.
173. Brodsky, L., Reidy, M. & Stanievich, J.F. (1987). The effects of suctioning techniqies on the distal tracheal mucosa in intubated low birth-weight infants. International Journal of Pediatric Otor- hinolaryngology 14, 1-14.
174. Kerr, K.M. (2001). Pulmonary preinvasive neoplasia. Journal of Clinical Pathology 54, 257-271.
175. Greenberg, A.K., Yee, H. & Rom, W.N. (2002). Preneoplastic lesions of the lung. Respiratory Research 3, 20-29.
176. Edwards, D. (2006). MGK-264 Reregistration Eligibility Decision. Notice of availability. Docket ID number EPA-HQ-OPP-2005-0040-0041. Federal Register 71, 42,381-42,383. Available at: http://www.regulations.gov/ fdmspublic/component/main (Accessed 09.01.09).
177. Osimitz, T.G., Droege, W. & Finch, J.M. (2007). Toxicologic significance of histologic change in the larynx of the rat following inhalation exposure: a critical review. Toxicology & Applied Pharmacology 225, 229-237.
178. Jetten, A.M. (1989). Multistep process of squamous differentiation in tracheobronchial epithelial cells in vitro: analogy with epidermal differentiation. Environmental Health Perspectives 80, 149-160.
179. Eckert, R.L., Crish, J.F. & Robinson, N.A. (1997). The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiological Reviews 77, 397-424.
180. Jetten, A.M. & Harvat, B. (1997). Epidermal differentiation and squamous metaplasia: from stem cell to cell death. Journal of Dermatology 24, 711-725.
181. Presland, R.B. & Dale, B.A. (2000). Epithelial structural proteins of the skin and oral cavity: function in health and disease. Critical Reviews in Oral Biology & Medicine 11, 383-408.
182. Levitt, M.L., Gazdar, A.F., Oie, H.K., Schuller, H.
183. & Thacher, S. (1990). Cross-linked envelope related markers for squamous differentiation in human lung cancer cell lines. Cancer Research 50, 120-128.
184. Vollberg, T.M., George, M.D., Nervi, C. & Jetten, A.M. (1992). Regulation of type I and type II transglutaminase in normal human bronchial epithelial and lung carcinoma cells. American Journal of Respiratory Cellular & Molecular Biology 7, 10-18.
185. Said, J.W., Nash, G., Sassoon, A.F., Shintaku, LP. & Banks-Schlegel, S. (1983). Involucrin in lung tumours: A specific marker for squamous differentiation. Laboratory Investigation 49, 563-568.
186. Barth, P.J., Koch, S., Muller, B., Unterstab, F., von Wichert, P. & Moll, R. (2000). Proliferation and number of Clara cell 10-kDa protein (CClO)-reac- tive epithelial cells and basal cells in normal, hyperplastic and metaplastic bronchial mucosa. Virchows Archiv 437, 648-655.
187. Gray, A.C., McLeod, J.D. & Clothier, R.H. (2005). Modelling squamous metaplasia in an in vitro bronchial cell culture model: a flow cytometric analysis. ALTEX 22, Special Issue, 343.
188. Gray, A.C., Clothier, R.H. & McLeod, J.D. (2007). Identification and manipulation of transglutaminase isoforms and activity for the detection of squamous metaplasia in tracheobronchial cells in vitro. Toxicology 231, 118-119.
189. Gray, AC. & Clothier, R.H. (2001). The use of an in vitro submerged keratinocyte model to predict induction of squamous metaplasia. Toxicology in Vitro 15, 427-431.
190. Gray, A.C., Garle, M.J. & Clothier, R.H. (1999). Fluorescein cadaverine incorporation as a novel technique for the characterization of terminal differentiation in keratinocytes. Toxicology in Vitro 13, 773-778.
191. Gray, A.C., Gobert, N., Corry, D., Clothier, R.H. & McLeod, J.D. (2007). Modelling squamous metaplasia in the respiratory tract: An in vitro inhalation model to identify irritants and carcinogens. BfR congress on Alternative Test Methods in Inhalation Toxicology, 7-9 May 2007, Berlin, Germany. Available at: http://www.ctw-congress.de/atmit/atmit 07 program me-abstracts.pdf (Accessed 09.01.09).
192. Moore, P., Ogilvie, J., Horridge, E., Mellor, I.R. & Clothier, R.H. (2005). The development of an innervated epithelial barrier model using a human corneal cell line and ND7/23 sensory neurons. European Journal of Cell Biology 84, 581-592.
193. Seagrave, J.C, McDonald, J.D., Bedrick, E., Edgerton, E.S., Gigliotti, A.P., Jansen, J.J., Ke, L., Naeher, L.P., Seilkop, S.K., Zheng, M. & Mauderly, J.L. (2006). Lung toxicity of ambient particulate matter from south eastern U.S. sites with different contributing sources: relationships between composition and effects. Environmental Health Perspectives 114, 1387-1393.
194. McDonald, J., Barr, E. & White, R. (2004). Design, characterization, and evaluation of a small-scale diesel exhaust exposure system. Aerosol Science & Technology 38, 62-78.
195. Nikula, K.J., Finch, G.L., Westhouse, R.A., Sea- grave, J.C, Mauderly, J.L., Lawson, D.R. & Gure- vich, M. (1999). Progress in Understanding the Toxicity of Gasoline and Diesel Engine Exhaust Emissions. SAE Technical Paper Series 1999-01-
196. 2250, 13pp. Warrendale, PA, USA: SAE International.
197. Seagrave, J.C, Mauderly, J.L., Zielinska, B., Sag- ebiel, J., Whitney, K., Lawson, D.R. & Gurevich, M. (2000). Comparative Toxicity of Gasoline & Diesel Engine Emissions. SAE Technical Paper Series 2000-001-2214, 5pp. Warrendale, PA, USA: SAE International.
198. Seagrave, J.C, Mauderly, J.L. & Seilkop, S.K. (2003). In vitro relative toxicity screening of combined particulate and semivolatile organic fractions of gasoline and diesel engine emissions. Journal of Toxicology & Environmental Health 66, 1113-1132.
199. Seagrave, J.C, McDonald, D. & Reed, M.D. (2004). Respiratory toxicity testing: Alternatives to inhalation exposure. In Respiratory Tract - Interpretations from Molecules to Meta Analysis (ed. U. Heinrich), pp. 205-217. Stuttgart, Germany: Fraunhofer IRB Verlag.
200. Seagrave, J.C. & Nikula, K.J. (2000). Multiple modes of responses to air pollution particulate materials in A549 alveolar type II cells. Inhalation Toxicology 12, 247-260.
201. Seagrave, J.C, McDonald, J.D., Gigliotti, A.P., Nikula, K.J., Seilkop, S.K., Gurevich, M. & Mauderly, J.L. (2002). Mutagenicity and in vivo toxicity of combined particulate and semivolatile organic fractions of gasoline and diesel engine emissions. Toxicological Sciences 70, 212-226.
202. Seagrave, J.C, Dunaway, S., Hayden, P., McDonald, J.D., Stidley, C. & Mauderly, J.L. (2007). Responses of differentiated primary human lung epithelial cells to exposure to diesel exhaust at an air-liquid interface. Experimental Lung Research 33, 27-51.
203. Seagrave, J.C, McDonald, J.D. & Mauderly, J.L. (2005). In vitro versus in vivo exposure to combustion emissions. Experimental Toxicology & Pathology 57, 233-238.
204. Combes, R., Balls, M., Illing, P., Bhogal, N., Dale, J., Duve, G., Feron, V., Grindon, C, Gulden, M., Loizou, G., Priston, R. & Westmoreland, C. (2006). Possibilities for a new approach to chemicals risk assessment - The report of a FRAME Workshop. ATLA 34, 621-649.
205. Phalen, R.F., Oldham, M.J. & Nel, A.E. (2006). Tracheobronchial particle dose considerations for in vitro toxicology studies. Toxicological Sciences 92, 126-132.
206. Fentem, J., Chamberlain, M. & Sangster, B. (2004). The feasibility of replacing animal testing for assessing consumer safety: a suggested future direction. ATLA 32, 617-623.
207. Crystal, R.G., Bitterman, P.B., Mossman, B., Schwarz, M.I., Sheppard, D., Almasy, L., Chapman, H.A., Friedman, S.L., King Jr, T.E., Leinwand, LA., Liotta, L., Martin, G.R., Schwartz, D.A., Schultz, G.S., Wagner, CR. & Musson, R.A. (2002). Future research directions in idiopathic pulmonary fibrosis: Summary of a National Heart, Lung, and Blood Institute working group. American Journal of Respiratory & Critical Care Medicine 166, 236- 246.
208. Greenwell, L., Roggen, E., Holder, J., Carthew, C, Westmoreland, C. & Fentem, J. (2005). Strategy for in vitro alternatives to inhalation toxicology: where do we begin? ALTEX 22, Special Issue, 256.
209. Richards, R.J., Oreffo, V.I.C. & Lewis, R.W. (1990).
210. Clara cell cultures from the mouse and their reaction to bronchiolar toxins. Environmental Health Perspectives 85, 119-127.
211. Carthew, P., Fletcher, S., White, A., Harries, H. & Weber, K. (2006). Transcriptomic and histopathol- ogy changes in rat lung after intratracheal instillation of polymers. Inhalation Toxicolology 18, 227-245.
212. Notingher, I. (2007). Raman Spectroscopy cell- based biosensors. Sensors 7, 1343-1358.
213. Gonda, I. (2006). Systemic delivery of drugs to humans via inhalation. Journal of Aerosol Medicine 19, 47-53.
214. Kesten, S., Jara, M., Wentworth, C. & Lanes, S. (2006). Safety pooled clinical trial analysis of tiotropium. Chest 130, 1695-1703.
215. Panning, C.A. & DeBisschop, M. (2003). Tiotropium: an inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease. Pharmacotherapy 23, 183-189.
216. Anon. (2006). The Biopharmaceutics Classification System (BCS) Guidance. Silver Spring, MD, USA: Center for Drug Evaluation and Research, U.S. Food and Drug Administration. Available at: http://www.fda.gov/cder/OPS/ BCS-guidance.htm (Accessed 09.01.09).
217. Manford, F., Tronde, A., Jeppsson, A.B., Patel, N., Johansson, F. & Forbes, B. (2005). Drug permeability in 16HBE14o- airway cell layers correlates with absorption from the rat lung. European Journal of Pharmaceutical Science 26, 215-220.
218. Forbes, B. (2006). Continuous respiratory epithelial cell culture models: a critical appraisal of their use for biopharmaceutical classification purposes. Respiratory Drug Delivery 10, 229-238.
219. dos Santos, M.A., Bosquillon, C, Russomano, T., Falcão, F., Martinelli, L., Marriott, C. & Forbes, B. (2006). Development of a diffusion chamber to evaluate in vitro respiratory epithelial cell layer permeability in microgravity. Paper given at the 54th International Congress of Aviation & Space Medicine, 10-14 September 2006, Banglaore, India. Available at: http://www.pucrs.br/feng/ microg/papers/2006-o.htm (Accessed 09.01.09).
220. Grenha, A., Grainger, C.I., Dailey, L.A., Seijo, B., Martin, G.P., Remuñán-López, C. & Forbes, B. (2007). Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro. European Journal of Pharmaceutical Sciences 31, 73-84.
221. Sarpong, S.B., Zhang, L.Y. & Kleeberger, S.R. (2003). A novel mouse model of experimental asthma. International Archives of Allergy & Immunology 132, 346-354.
222. Fitzgerald, M.F. & Fox, J.C. (2007). Emerging trends in the therapy of COPD: novel anti-inflammatory agents in clinical development. Drug Discovery Today 12, 479-486.
223. Olivera, D.S., Boggs, S.E., Beenhouwer, C, Aden, J. & Knall, C. (2007). Cellular mechanisms of mainstream cigarette smoke-induced lung epithelial tight junction permeability changes in vitro. Inhalation Toxicology 19, 13-22.
224. Borm, P.J.A., Robbins, D., Haubold, S., Kuhlbusch, T., Fissan, H., Donaldson, K., Schins, R., Stone, V., Kreyling, W., Lademann, J., Krutmann, J., Warheit, D. & Oberdorster, E. (2006). The potential risks of nanomaterials: a review carried out for ECETOC. Particle & Fibre Toxicology, 3:11. doi:10.1186/1743-8977-3-ll. Available at: http://www. particleandfibretoxicology.eom/content/3/ 1/11 (Accessed 09.01.09).
225. Maynard, A.D., Aitken, R.J., Butz, T., Colvin, V., Donaldson, K., Oberdorster, G., Philbert, M.A., Ryan, J., Seaton, A., Stone, V., Tinkle, S.S., Tran, L., Walker, N.J. & Warheit, D.B. (2006). Safe handling of nanotechnology. Commentary. Nature, London 444, 267-269.
226. Tran, C.L., Donaldson, K., Stones, V., Fernandez, T., Ford, A., Christofi, N., Ayres, J.G., Steiner, M., Hurley, J.F., Aitken, R.J. & Seaton, A. (2005). A Scoping Study to Identify Hazard Data Needs for Addressing the Risks Presented by Nanoparticles & Nanotubes. London, UK: Defra. Available at: http://www.defra.gov.uk/ENVIRONMENT/nanotech/research/pdf/ hazarddata-scoping.pdf (Accessed 15.09.08).
227. Anon. (2007). Characterising the Potential Risk Posed by Engineered Nanoparticles. A Second UK Government Research Report, 100pp. London, UK: Department for Environment, Food and Rural Affairs. Available at: http://www.defra.gov.uk/environment/nanotech/research/pdf/nanoparticles- riskreport07.pdf (Accessed 09.01.09).
228. Singh, S. & Nalwa, H.S. (2007). Nanotechnology and health safety - toxicity and risk assessments of nanostructured materials on human health. Journal of Nanoscience & Nanotechnology 7, 3048-3070.
229. Donaldson, K., Aitken, R., Tran, L., Stone, V., Duffin, R., Forrest, G. & Alexander, A. (2006). Carbon nanotubes: A review of their properties in relation to pulmonary toxicology and workplace safety. Toxicological Sciences 92, 5-22.
230. 2: role of the specific surface area and of surface methylation of the particles. Toxicology & Applied Pharmacology 222, 141-151.
231. Oberdorster, G. (2007). Biokinetics and effects of nanoparticles. In Nanotechnology - Toxicological Issues & Environmental Safety & Environmental Safety (ed. P.P. Simeonova, N. Opopol & M.I. Luster), pp. 15-51. Dordrecht, The Netherlands: Springer, Netherlands.
232. Borm, J.A. & Kreyling, W. (2004). Toxicological hazards of inhaled nanoparticles - potential implications for drug delivery. Journal of Nanoscience and Nanotechnology 4, 1-11.
233. Rothen-Rutishauser, B., Mühlfeld, C, Blank, F., Musso, C. & Gehr, P. (2007). Translocation of particles and inflammatory responses after exposure to fine particles and nanoparticles in an epithelial airway model. Particle & Fibre Toxicology 4: 9. doi:10.1186/1743-8977-4-9 Available at: http://www.particleandfibretoxicology.com/content/4/1/9 (Accessed 09.01.09).
234. Braydich-Stolle, L., Hussain, S., Schlager, J.J. & Hofmann, M.C. (2005). In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicological Sciences 88, 412-419.
235. Hussain, S.M., Hess, K.L., Gearhart, J.M., Geiss, K.T. & Schlager, J.J. (2005). In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicology in Vitro 19, 975-983.
236. Mühlfeld, C, Rothen-Rutishauser, B., Vanhecke, D., Blank, F., Gehr, P. & Ochs, M. (2007). Visualization and quantitative analysis of nanoparticles in the respiratory tract by transmission electron microscopy. Particle & Fibre Toxicology 4: 1. doi:10.1186/1743-8977-4-ll. Available at: http://www.particleandfibretoxicology.com/content/4/1/11 (Accessed 09.01.09).
237. Zeka, A., Sullivan, J.R., Vokonas, P.S., Sparrow, D. & Schwartz, J. (2006). Inflammatory markers and particulate air pollution: characterizing the pathway to disease. International Journal of Epidemiology 35, 1347-1354.
238. Duffin, R., Tran, L., Brown, D., Stone, V. & Donaldson, K. (2007). Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: Highlighting the role of particle surface area and surface reactivity. Inhalation Toxicology 19, 849-856.
239. Teeguarden, J.G., Hinderliter, P.M., Orr, G., Thrall, B.D. & Pounds, J.G. (2007). Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicological Science 95, 300-312.
240. Morin, J-P., Rumigny, J.F., Bion, A. & Dionnet, F. (2002). Isoflavones protect against diesel engine exhaust injury in organotypic culture of lung tissue. Environmental Toxicology & Pharmacology 12, 213-220.
241. Morin, J-P. (2007). Multidisciplinary approaches to airborne pollutant health related issues (MAAPHRI): development and pre- validation of alternatives to in vivo inhalation. BfR congress on Alternative Test Methods in Inhalation Toxicology, 7-9 May 2007, Berlin, Germany. Available at: http://www.ctw-congress.de/atmit/atmit07programme-abstracts.pdf (Accessed 09.01.09).
242. Hasson, V., Loriot, S. & Morin, J-P. (2007). Diesel engine emission toxicology. Comparison of in vitro versus in vivo aerosol exposures toxicity patterns. BfR congress on Alternative Test Methods in Inhalation Toxicology, 7-9 May 2007, Berlin, Germany. Available at: http://www.ctw-congress.de/atmit/atmit07programme-abstracts.pdf (Accessed 09.01.09).
243. Kittelson, D.B., Arnold, M. & Watts Jr, W.F. (1999). Review of Diesel Particulate Matter Sampling Methods - Final Report, 64pp. Minneapolis, MN, USA: University of Minnesota, Department of Mechanical Engineering. Available at: http://www.me.umn.edu/centers/cdr/reports/EPAreport3. pdf (Accessed 09.01.09).
244. Lambré, C.R., Aufderheide, M., Bolton, R.E., Fubini, B., Haagsman, H,P., Hext, P.M., Jorissen, M., Landry, Y., Morin, J-P., Nemery, B., Nette- sheim, P., Pauluhn, J., Richards, R.J., Vickers, A.E.M. & Wu, R. (1996). In vitro tests for respiratory toxicity. The report and recommendations of ECVAM Workshop 18. ATLA 24, 671-681.
245. d'Yvoire, M.B., Prieto, P., Blaauboer, B.J., Bois, F.Y., Boobis, A., Brochot, C., Coecke, S., Freidig, A., Gundert-Remy, U., Hartung, T., Jacobs, M.N., Lave, T., Leahy, D.E., Lennernas, H., Loizou, G.D., Meek, B., Pease, C., Rowland, M., Spendiff, M., Yang, J. & Zeilmaker, M. (2007). Physiologically- based kinetic modelling (PBK Modelling): Meeting the 3Rs Agenda. The report and recommendations of ECVAM Workshop 63. ATLA 35, 1-11.
246. Bakand, S., Winder, C, Khalil, C. & Hayes, A. (2006). A novel in vitro exposure technique for toxicity testing of selected volatile organic compounds. Journal of Environmental Monitoring 8, 100-105.
247. Geiser, M. & Lang, D. (2007). In vitro replica of the inner surface of the lungs for the study of particle-cell interaction. ALTEX 24, Special Issue, 83-85.